GlassScriptPhysician profile
Nancy M Gideon
NPI 1609871797
$1,861.11
in general payments reported to CMS, 2019-2025
17 companies · $249 in 2025
The $249 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $121 · 2021: $215 · 2022: $188 · 2023: $190 · 2024: $566 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $332.94 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi-Aventis U.S. LLC | $277.18 | 2024-2025 | |
| Sanofi Pasteur INC. | $232.51 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $184.28 | 2019-2023 | Jornay Pm |
| Pfizer INC. | $160.67 | 2019-2025 | |
| Verrica Pharmaceuticals INC. | $142.57 | 2024 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $108.84 | 2020-2022 | |
| Tris Pharma INC | $93.76 | 2019-2025 | Dyanavel Xr |
| Genzyme Corporation | $80.32 | 2022-2024 | |
| Sobi, INC | $58.93 | 2019-2020 | |
| Glaxosmithkline, LLC. | $41.83 | 2019 | |
| Shire North American Group INC | $30.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.96 | 2023-2024 | Flumist Quadrivalent |
| Organon LLC | $27.37 | 2025 | Nexplanon |
| Supernus Pharmaceuticals, INC. | $25.49 | 2022-2023 | Qelbree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $23.34 | 2024 | Azstarys |
| Adlon Therapeutics L.P. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Gideon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.